Adenosine Diphosphate Stimulates the Endothelial Release of Tissue-Type Plasminogen Activator but not von Willebrand Factor from Isolated-Perfused Rat Hind Limbs

Summary

The acute release of tissue-type plasminogen activator (t-PA) activity and of von Willebrand Factor (vWF) antigen from vascular endothelium was studied ex vivo using the rat hindquarter isolated perfusion model. The release of these proteins has been reported to occur simultaneously in response to a variety of endothelial cell agonists including bradykinin, thrombin and platelet activating factor. It has therefore been suggested that similar endothelial cell pathways and mechanisms are involved in the release of t-PA and vWF in vivo.

This paper shows that the releases of t-PA and of vWF are not always closely linked and may depend on the agonist utilized to effect release. In our hands, the bradykinin-induced release of these proteins appears to be essentially identical, but this is not true for adenosine diphosphate (ADP). Rather, ADP is capable of causing the acute release of t-PA without the simultaneous release of vWF in the ex vivo rat hindquarter model. This indicates that the bradykinin- and ADP-induced pathways for t-PA release are probably distinct and that the releases of t-PA and vWF are not as closely linked as previously believed.

• References

• 1 Prowse CV, MacGregor IR. Regulation of the plasminogen activator level in blood. In: Tissue-Type Plasminogen Activator (t-PA): Physiological and Clinical Aspects Kluft C. ed Boca Raton CRC Press 1988; 2: 49-66
• 2 Emeis JJ. Mechanisms involved in short-term changes in blood levels of t-PA. In: Tissue-Type Plasminogen Activator (t-PA): Physiological and Clinical Aspects Kluft C. ed. Boca Raton CRC Press 1988; 2: 21-36
• 3 Tranquille N, Emeis JJ. On the role of calcium in the acute release of tissue-type plasminogen activator and von Willebrand factor from the rat perfused hindleg region. Thromb Haemostas 1991; 66: 479-483
• 4 Tranquille N, Emeis JJ. Protein synthesis inhibition by cycloheximide does not affect the acute release of tissue-type plasminogen activator. Thromb Haemostas 1989; 61: 442-447
• 5 Tranquille N, Emeis JJ. The Involvement of products of the phos-pholipase pathway in the acute release of tissue-type plasminogen activator from perfused rat hindlegs. Eur J Pharmacol 1992; 213: 285-292
• 6 Tranquille N, Emeis JJ. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region. Thromb Haemostas 1990; 63: 454-458
• 7 Karlan BY, Clark AS, Littlefield BA. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators. Biochem Biophys Res Commun 1987; 142: 147-154
• 8 Nakajima K. A possible mechanism of vasoactive agents on plasminogen activator release in isolated perfused pig ears. Thromb Res 1983; 29: 187-196
• 9 Kitaguchi H, Hijikata A, Hirata M. Effect of thrombin on plasminogen activator release from isolated perfused dog leg. Thromb Res 1979; 16: 407-420
• 10 McArthur MM, MacGregor IR, Prowse CV, Hunter NR, Dawes J, Pepper DS. The use of human endothelial cells cultured in flat wells and on microcarrier beads to assess tissue plasminogen activator and Factor VUI-related antigen release. Thromb Res 1986; 41: 581-587
• 11 Booyse FM, Bruce R, Dolenak D, Grover M, Casey LC. Rapid release and deactivation of plasminogen activators in human endothelial cell cultures in the presence of thrombin and ionophore A23187. Semin Thromb Hemost 1986; 12: 228-230
• 12 Ruggeri GM, Ware J. Von Willebrand Factor. FASEB J 1993; 7: 305-316
• 13 Colman RW. Aggregin: A platelet ADP receptor that mediates activation. FASEB J 1990; 4: 1425-1435
• 14 Houston DS, Shepard JT, Van Houtte PM. Adenine nucleotides serotonin and endothelium-dependent relaxations to platelets. Am J Physiol 1985; 248: H389-H395